高劑量維他命C癌症| HIGH DOSAGE VITAMIN C THERAPY

High-Dose Vitamin C and Cancer Treatment | Supportive Cancer Therapy

How Can High-Dose Vitamin C Help Cancer Patients?

High-dose Vitamin C

High-dose vitamin C is administered intravenously at doses far exceeding those achievable through oral supplementation, allowing blood concentrations to reach pharmacological levels that cannot be attained through oral intake.【28】 In the field of integrative medicine in Hong Kong, high-dose intravenous vitamin C (IV Vitamin C) is among the commonly considered options for supportive cancer care, immune support, antioxidant support, and the management of chronic fatigue. Oral vitamin C is limited by the absorption capacity of the gastrointestinal tract. Even with high oral intake, plasma concentrations are difficult to increase beyond the micromolar range. In contrast, intravenous administration of high-dose vitamin C delivers it directly into the bloodstream, achieving millimolar concentrations and potentially producing different physiological effects.【28】 Research suggests that at these concentrations, vitamin C may induce selective oxidative stress through the generation of hydrogen peroxide.【18, 19, 20】 It may also support the antioxidant and repair functions of normal cells, while potentially helping to improve quality of life and alleviate discomfort associated with chemotherapy or radiotherapy, such as fatigue, loss of appetite, and insomnia.【9, 29, 31】 Relevant assessments are conducted before treatment, including kidney function tests and screening for G6PD deficiency, to evaluate safety. High-dose vitamin C is positioned as a supportive measure and does not replace conventional cancer treatment. Its use should be coordinated with the patient’s primary treating doctor. The appropriate dosage (medium, high, or ultra-high dose), frequency, and treatment schedule must be determined by a doctor based on the individual’s health condition, intended purpose, and assessment results. If you would like to find out whether high-dose vitamin C is suitable for you, you are welcome to book a consultation.

The History and Science of High-Dose Vitamin C

Vitamin C has been used for the prevention of colds and the treatment of scurvy for more than half a century. Dr. Linus Carl Pauling, an American chemist and two-time Nobel Prize laureate, and his research team explored the potential supportive role of high-dose intravenous vitamin C in patients with cancer.【1, 2, 3】 Their observations suggested that, in some cases, high-dose intravenous vitamin C might help support immune function, promote overall well-being, and potentially contribute to improvements in quality of life.【22, 26, 27】

Subsequent laboratory and clinical studies have continued to investigate the effects of high concentrations of vitamin C on cancer cells. Research suggests that vitamin C at pharmacological concentrations may act through several mechanisms, including the generation of hydrogen peroxide (which may selectively affect cancer cells),【18, 19, 20】 modulation of oxidative stress,【20, 25】 immune modulation, and potential synergistic effects when combined with standard cancer treatments.【6, 7, 9, 30, 32】 Further large-scale clinical studies are still needed to confirm its clinical benefits. Therefore, at BMS Clinic, high-dose vitamin C is positioned strictly as a supportive measure and not as a replacement for conventional cancer treatment.
High-dose vitamin C is commonly used as a supportive approach in cancer care.【4, 5, 9, 32】 Beyond supportive cancer care, high-dose vitamin C is also used or studied in relation to:
  • Supporting immune system function
  • Providing antioxidant support and potentially helping regulate chronic inflammatory responses
  • Supporting collagen synthesis and wound healing
  • Managing chronic fatigue and supporting the body’s response to stress
  • Providing supportive care alongside the management of diabetes and cardiovascular conditions

The Efficacy of High-Dose Vitamin C as an Adjunctive Therapy

Vitamin C is an antioxidant nutrient that plays an essential role in protecting the body against oxidative damage and supporting its natural defences against infections. In addition to increasing vitamin C concentrations in the bloodstream, research suggests that intravenous vitamin C at appropriate doses may provide supportive benefits during radiotherapy or chemotherapy. It may help reduce certain treatment-related side effects, including nausea, loss of appetite, fatigue, depression, insomnia, dizziness, reduced immune function, and general weakness, potentially helping people with cancer maintain a better quality of life.【4, 5, 7, 9, 29, 31】 Other research suggests that one possible explanation for the supportive effects of vitamin C at appropriate concentrations is its involvement in cancer cell iron metabolism. This may make tumour cells more sensitive to radiation and chemotherapy, potentially increasing their susceptibility to treatment while having a different effect on normal cells.【25】

Some Research and Perspectives on High-Dose Vitamin C

Different concentrations of vitamin C can have different effects in the human body. When the body’s vitamin C concentration reaches 0.1 mM, vitamin C acts as an effective antioxidant, helping to slow down or prevent the oxidation of molecules. However, when vitamin C concentrations reach higher levels, its breakdown process can generate hydrogen peroxide (a type of reactive oxygen species), which can damage tissues and DNA. Normal cells have several mechanisms for eliminating hydrogen peroxide, keeping its levels very low and helping to prevent cellular damage. Compared with normal cells, cancer cells generally have a weaker capacity to remove hydrogen peroxide. As a result, hydrogen peroxide may have the potential to damage tumour cells.【18, 19, 20】
Research suggests that tumour tissues contain abnormally high levels of redox-active iron molecules, which may arise as by-products of altered mitochondrial metabolism. These molecules can react with vitamin C to generate hydrogen peroxide and free radicals derived from hydrogen peroxide. These free radicals are believed to selectively cause DNA damage in cancer cells, potentially leading to cancer cell death and increasing the sensitivity of cancer cells to radiotherapy and chemotherapy.【25】
Tumour angiogenesis is essential for tumour growth and metastasis, as it provides a supply of nutrients and a system for removing waste products. Research suggests that high-dose vitamin C may support collagen synthesis, thereby strengthening the structural layers between cells. This may help limit the ability of cancer cells to penetrate these structural barriers, potentially inhibiting the formation of new blood vessels and reducing tumour growth and spread.
A study investigated the clinical usefulness of intravenous vitamin C in relation to quality of life through a prospective observational study. It examined changes in patients’ quality of life following intravenous vitamin C administration and evaluated its safety in people with cancer. The results showed that after four weeks of intravenous vitamin C administration, patients experienced significant improvements in their Global Health Status scores and Functional Scale scores. In addition, subjective symptom scores, particularly those related to fatigue and insomnia, also improved significantly. Based on these findings, the study suggested that intravenous vitamin C could be administered safely and may help improve the quality of life of people with cancer.【31】 A study published in Japan in 2012 also indicated that intravenous vitamin C may help improve or maintain the quality of life of people with cancer. After two weeks of intravenous vitamin C administration, the severity of several symptoms, including fatigue, insomnia, and constipation, decreased significantly. After four weeks, pain began to improve noticeably, while overall quality-of-life scores also showed significant improvement.【31】

Deconstructing the Limitations of Oral Vitamin C

香港高劑量維他命C靜脈注射治療室 - 治本醫務中心高劑量維他命C | IV Vitamin C | High Dosage Vitamin C Hong Kong
In Hong Kong, there are numerous high-dose oral vitamin C products available on the market. However, can our bodies really absorb all of the vitamin C we consume? The human body has a tightly regulated mechanism for vitamin C absorption. As a result, regardless of how much vitamin C is taken orally, blood vitamin C concentrations remain limited, generally within the range of several tens of micromoles (μmol/L).【28】 Furthermore, taking high doses of vitamin C orally on a regular basis may irritate the gastrointestinal tract and cause discomfort, vomiting, abdominal pain, and diarrhoea. In Europe and the United States, intravenous vitamin C infusions are a relatively common method of vitamin C supplementation. This approach delivers vitamin C directly into the bloodstream, allowing blood concentrations to reach levels that may be 100 times or more higher than those achievable through oral intake.【28】 In addition, intravenous administration of high-dose vitamin C bypasses the digestive system, avoiding the gastrointestinal irritation that may occur with high-dose oral supplementation. This is one reason why some people choose intravenous vitamin C (IV Vitamin C) as an alternative way to receive vitamin C. Compared with Europe and the United States, high-dose intravenous vitamin C remains relatively uncommon in Hong Kong. Research has shown that intravenous vitamin C can produce higher circulating vitamin C concentrations in the blood than either liposomal or non-liposomal oral vitamin C. Although liposomal vitamin C produces higher circulating concentrations than non-liposomal vitamin C, the difference between the two is relatively modest.
靜脈注射高劑量維他命C在血液所產生的維他命 C 循環濃度高於比各種口服(脂質體和非脂質體)維他命C
Not everyone is suitable for high-dose vitamin C therapy. The following individuals are advised to consult a doctor before considering this approach:
  • Individuals with a history of kidney stones 【10, 11, 12】
  • Individuals with impaired kidney function or those undergoing dialysis 【10, 11, 12】
  • Individuals with haemochromatosis
  • Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency
A study compared circulating vitamin C concentrations in the blood following different methods of vitamin C administration:
  • Intravenous vitamin C
  • Oral liposomal vitamin C
  • Oral non-liposomal vitamin C
高劑量維他命C | IV Vitamin C | High Dosage Vitamin C

Who might consider consulting a doctor about high-dose Vitamin C (IV Vitamin C)?

Individuals who may consider consulting a doctor for information about high-dose vitamin C infusions include:
  • Individuals with tumours
  • Cancer survivors
  • Individuals with chronic conditions or immune system disorders
  • Individuals with inflammatory conditions
高劑量維他命C的希望
High-dose vitamin C is generally considered to have a reasonable safety profile when administered under professional medical supervision.【4, 5, 8】 However, mild side effects may still occur. The following precautions should be considered: Precautions:
  • Monitor osmolarity, infusion rate, accompanying nutrients, dietary coordination, and any discomfort that may occur during administration.
  • Monitor the vitamin C dosage carefully.
  • Some individuals may experience discomfort during high-dose vitamin C administration, particularly if they are not accustomed to the dosage. Possible symptoms include headaches, stomach cramps, dizziness, nausea, and thirst.
Possible side effects:
  • Gastrointestinal discomfort (particularly with oral administration).
  • Mild nausea or diarrhoea.
  • Prolonged use of high doses may increase the risk of kidney stones. Adequate hydration and appropriate monitoring are important.【10, 11, 12, 13, 14, 15】
A doctor should assess the individual’s health condition before administration, with regular monitoring and follow-up throughout the treatment period.

The Safety of
High-Dose Vitamin C!
IV Vitamin C

The following individuals should not receive high-dose intravenous vitamin C infusions:

  • Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
  • Patients with kidney failure who require dialysis. 【10, 11, 12】
  • Individuals with malnutrition.
  • Individuals experiencing dehydration.

Although serious side effects are not commonly reported, the following symptoms may occur:

  • Irritation or pain at the intravenous infusion site Reducing the infusion rate may help relieve the discomfort.
  • Dry mouth or increased thirst High-dose vitamin C infusion may have a diuretic effect. Drinking adequate amounts of water during or after the infusion may help maintain hydration.
  • Potential effects on blood glucose levels and glucose testing Vitamin C has a chemical structure similar to glucose. At high concentrations, it may interfere with certain blood glucose monitoring devices and produce inaccurate readings. This is particularly important for individuals with diabetes, who should inform their medical team and follow appropriate monitoring guidance.
  • Fatigue in some individuals
    A small number of individuals may feel tired after completing an infusion. If this occurs, adequate rest and monitoring of symptoms are recommended.
  • Increased bowel activity
    High-dose vitamin C may stimulate intestinal activity, potentially resulting in more frequent bowel movements or softer stools.
癌症與營養

Research on High-Dose Vitamin C

Numerous studies suggest that high-dose vitamin C has potential anticancer properties. According to information from the US National Cancer Institute (NCI), high concentrations of vitamin C may generate reactive oxygen species (ROS), which can selectively damage cancer cells while causing less harm to normal cells.【18, 19, 20】 In addition, some studies suggest that high-dose vitamin C may help reduce chemotherapy-related side effects and improve quality of life.【9, 29, 31】

Summary Regarding High-Dose Vitamin C

  • Research on high-dose vitamin C and cancer cells: Vitamin C can break down in the body and generate hydrogen peroxide (H2O2), a type of reactive oxygen species (ROS) capable of damaging tissues and DNA. Studies have also suggested that, compared with normal cells, tumour cells have a weaker ability to eliminate harmful hydrogen peroxide. One area of research into high-dose vitamin C is therefore based on increasing intracellular hydrogen peroxide levels, potentially causing damage to cancer cells and triggering apoptosis (programmed cell death). 【18】
  • Some human clinical trials suggest that high-dose vitamin C may help alleviate certain chemotherapy-related side effects, including fatigue and nausea, while potentially improving appetite and quality of life. 【9, 29, 31】
  • Research indicates that oral vitamin C cannot achieve the pharmacological blood concentrations associated with certain anticancer mechanisms. Intravenous administration is required to achieve concentrations of approximately 20 mM. 【18, 28】
  • Some laboratory studies have found that high-dose vitamin C may affect the proliferation of cancer cell lines in vitro, including prostate, pancreatic, liver, colorectal, mesothelioma, and neuroblastoma cells. 【18, 30】
  • Some animal studies have found that high-dose vitamin C may slow tumour cell growth. 【20】
  • Two human studies have suggested that intravenous high-dose vitamin C may help improve quality of life in patients with advanced cancer and may reduce certain cancer treatment-related side effects, such as nausea and vomiting. 【29, 31】
The information above is provided for educational purposes only and does not constitute medical advice or treatment recommendations. If you have any questions, please consult a qualified healthcare professional. High-dose vitamin C is intended as a supportive measure and does not replace conventional cancer treatment.

FAQ – High-Dose Vitamin C Therapy

Frequently Asked Questions

The cost of high-dose vitamin C varies across different countries. In Hong Kong, the price ranges from HK$2,500 to HK$3,500 per session (varies by dosage), typically charged in a treatment course of 10-session.

Due to the fact that the administration of high-dose vitamin C injections is a procedure that requires supervision by healthcare professionals, it must be conducted by qualified medical personnel to ensure the accuracy of infusion and the safety of the process.

High-dose vitamin C Therapy cannot replace traditional/conventional mainstream treatments such as chemotherapy, radiation therapy, cellular therapy, or immunotherapy. It is important to consult with your doctor to plan an appropriate adjunctive treatment plan and to coordinate with the treatment plan of mainstream conventional medicine.

The recommended dosage, duration, and frequency of treatment may vary depending on the individual’s condition and tolerance.

Typically, a single infusion of high-dose vitamin C ranges from 300ml to 500ml, and the administration time is approximately 60 to 90 minutes.

After diagnosis, the doctor will advise on the appropriate dosage, duration, and frequency of treatment.

High-dose vitamin C therapy can enhance immune function, and there are studies suggesting a potential reduction in the risk of developing cancer or its spread (further research is needed). It may also contribute to improving the effectiveness of chemotherapy and radiation therapy (further research is needed). Cancer patients, individuals in recovery, those with chronic diseases, or immune system disorders can consult with healthcare professionals and doctors to learn more about this treatment method.

Some overseas clinical studies suggest that high-dose IV Vitamin C, when used as supportive care alongside standard chemotherapy, may offer potential survival benefits in specific cancers (e.g., advanced pancreatic cancer). For example, a 2024 randomized phase II trial from the University of Iowa (a small study involving 34 patients with late-stage metastatic pancreatic cancer) reported that adding high-dose IV Vitamin C to chemotherapy extended median overall survival from about 8 months to 16 months, while also improving quality of life and reducing certain side effects. However, this is a single phase II result and has not been confirmed by large-scale phase III trials or broad consensus for reliably extending survival across all cancer types or patient groups. Hong Kong currently has no official research, clinical trials, or guidelines endorsing this as a standard approach for survival extension. Reviews from sources like the NCI and Mayo Clinic note possible benefits in treatment tolerance, but there is no evidence it cures cancer or dramatically improves prognosis on its own. At BMS Clinic, all IVC sessions are strictly supervised by registered doctors, with pre-screening (e.g., kidney function, G6PD deficiency) and coordination with your primary oncologist (Upon request) to ensure safety and avoid conflicts. It is suitable only as complementary support, not a replacement for mainstream treatment. Appropriate for patients in Cheung Sha Wan and Hong Kong—bring your medical records for a consultation: +852 2370 3001 or WhatsApp +852 9277 7808.

Under professional medical supervision, high-dose IV Vitamin C is generally safe and well-tolerated. Clinical trials (e.g., Mayo Clinic, NCI, and recent pancreatic cancer studies) show most patients experience no serious adverse events. Common mild side effects include minor discomfort at the IV site, dry mouth, slight nausea, or temporary blood sugar fluctuations (as IVC can interfere with some glucose tests). We pre-screen for risks like kidney function or G6PD deficiency to prevent complications. At BMS Clinic in Cheung Sha Wan, Hong Kong, we follow strict safety protocols for outpatient sessions. Suitable for most patients after individual assessment.

No, high-dose vitamin C does not cure cancer on its own, and there is no reliable evidence that it serves as a standalone cure for any type of cancer.

High-dose intravenous vitamin C (HDIVC, also known as pharmacological ascorbate) is best studied and utilized as a supportive adjunctive therapy in integrative oncology. Many experienced integrative doctors incorporate it alongside standard cancer treatments (such as chemotherapy, radiation, or immunotherapy) to help enhance treatment tolerance, support quality of life, and potentially improve clinical outcomes for suitable patients.

Recent evidence is encouraging in this supportive role:

  • A randomized Phase II clinical trial published in Redox Biology (2024) from the University of Iowa showed that adding high-dose IV vitamin C (75 g, three times per week) to standard chemotherapy (gemcitabine + nab-paclitaxel) in patients with stage IV metastatic pancreatic cancer nearly doubled median overall survival — from approximately 8 months with chemotherapy alone to 16 months with the combination. Progression-free survival also improved, and the addition was well tolerated without increasing severe side effects or harming quality of life.

Other Phase I/II studies and reviews have similarly reported benefits when HDIVC is used supportively, including:

  • Reduced fatigue, pain, and nausea
  • Better tolerance to chemotherapy and radiation
  • Potential protective effects on healthy tissues while exerting selective oxidative stress on cancer cells

Integrative doctors with expertise in this area often emphasize proper patient selection, precise dosing, and integration with conventional care to maximize these supportive benefits. Larger Phase III trials are ongoing to further clarify its role across different cancer types.

Key takeaway: High-dose IV vitamin C is not a cancer cure, but when thoughtfully incorporated by experienced integrative practitioners as part of a comprehensive plan, it shows promise as a safe, well-tolerated supportive option that may help improve survival and quality of life in certain settings. It should always complement — never replace — standard oncology care. Patients are encouraged to discuss it openly with a qualified doctor for personalized guidance.

The effectiveness of high-dose intravenous vitamin C (HDIVC) as a supportive therapy can vary noticeably between patients. This difference does not mean the approach is ineffective overall; rather, it often reflects how precisely the therapy is tailored to the individual — an area where experienced integrative doctors can make a meaningful difference.

Skilled integrative oncology practitioners focus on optimizing several key factors to improve the likelihood of benefit:

  1. Precise Dosage and Plasma Levels Benefits are linked to achieving high pharmacological blood concentrations (typically >10 mM), which only intravenous administration can reliably deliver. Integrative doctors carefully calculate and monitor doses to ensure therapeutic levels are reached safely.

  2. Frequency, Duration, and Timing Effective protocols commonly involve 2–3 infusions per week over an extended period, carefully timed with other treatments for better synergy.

  3. Integration with Standard Therapies Many integrative doctors report stronger supportive effects when HDIVC is thoughtfully combined with specific chemotherapies, radiation, or immunotherapy, potentially enhancing tolerance and outcomes while helping protect normal cells.

  4. Comprehensive Patient Assessment Experienced practitioners perform thorough screening (e.g., G6PD deficiency, kidney function) and consider the patient’s overall health, cancer stage, and individual biology.

  5. Personalized Sensitivity Profiling One helpful emerging tool used in some integrative settings is Circulating Tumor Cell (CTC) functional sensitivity testing. This lab analysis exposes a patient’s own circulating cancer cells to high-dose vitamin C (and other natural substances) to assess likely response.

    • High sensitivity on the test may indicate a greater chance of benefit from HDIVC.
    • Low sensitivity helps guide the doctor toward more suitable supportive options.

    This type of personalization allows integrative doctors to move beyond generic approaches and design regimens better matched to the patient’s unique cancer biology.

Bottom line: When administered with attention to detail by integrative doctors experienced in adjunctive therapies, high-dose IV vitamin C can provide meaningful supportive benefits for many patients — including better quality of life and, in some cases, improved survival metrics as seen in recent trials. Results are more consistent when the therapy is precisely executed and integrated into a broader, individualized care plan.

Important Safety Note: Under proper medical supervision with appropriate screening, HDIVC has demonstrated a good safety profile in clinical studies. It is intended as a complementary supportive approach, not a replacement for conventional cancer treatment. The best outcomes often occur through close collaboration between the patient’s oncologist and an experienced integrative doctor.

Disclaimer: This information is for educational purposes only and is not medical advice. Treatment decisions, including the use of any integrative therapies, should always be made in consultation with qualified healthcare professionals based on your individual situation.

References